Search Results - "G.B. Gaeta"

No Beneficial of Long-Term Analogue Treatment on the Clinical Outcome of Patients with Chronic Hepatitis Delta and Advanced Liver Disease. A Case-Control Study by Brancaccio, G, Fasano, M, Grossi, A, Santantonio, T, Gaeta, G.B

Get full text

Add-On Peginterferon Alfa-2a Significantly Reduces HBsAg Levels in HBeAg-Negative, Genotype D Chronic Hepatitis B Patients Fully Suppressed on Nucleot(s)ide Analogues Treatment: Final Results of the Hermes Study by Lampertico, P, Brunetto, M.R, Craxi, A, Gaeta, G.B, Rizzetto, M, Rozzi, A, Colombo, M

Get full text

Safety of Simeprevir-Based Treatment for Hepatitis C in Real Practice: Preliminary Results from the Stily Observational Study by Colombo, M, Russello, M, Forte, P, Lettieri, G, Milazzo, L, Gasbarrini, A, Ori, A, Palma, M, Termini, R, Gaeta, G.B

Get full text

An outbreak of acute hepatitis C GT1b in onco-hematological patients. Treatment with Sofosbuvir + Ledipasvir and concomitant chemotherapy by Brancaccio, G, Sorbo, M.C, Frigeri, F, Rizzo, V, Cantone, M, Genderini, F, Fabeni, L, Pinto, A, Perno, C.F, Ceccherini-Silberstein, F, Gaeta, G.B

Get full text

Declining prevalence and increasing awareness of hepatitis C virus infection in Italy: a population-based survey by Andriulli, A, Stroffolini, T, Valvano, M.R, Grattagliano, I, Ippolito, A.M, Grossi, A, Brancaccio, G, Coco, C, Russello, M, Smedile, A, Petrini, E, Martini, S, Gaeta, G.B, Rizzetto, M

Get full text

Sofosbuvir/Ribavirin treatment in patients with genotype 2, Hepatitis C Virus infection and symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life by Cerretelli, G, Gragnani, L, Monti, M, Arena, U, Fognani, E, Petraccia, L, Gianni, E, Sollima, S, Brancaccio, G, Galli, M, Gaeta, G.B, Zignego, A.L

Get full text

Effectiveness of Simeprevir Treatment for Hepatitis C in Real Practice: Preliminary Results from the Stily Italian Observational Study by Gaeta, G.B, Menzaghi, B, D’Offizi, G, Giorgini, A, Lazzarin, A, Babudieri, S, Brunetto, M, Fagiuoli, S, Simoni, L, Palma, M, Termini, R

Get full text

Efficacy and Tolerability of Simeprevir and Daclatasvir for 12 or 24 Weeks in HCV Genotype 1b-Infected Treatment-Naïve Patients with Advanced Fibrosis or Compensated Cirrhosis by Hezode, C, Almasio, P, Bourgeois, S, Buggisch, P, Brown, A, Diago, M, Horsmans, Y, Serfaty, L, Szalay, F, Gaeta, G.B, Planas, R, Schlag, M, Lonjon-Domanec, I, Gilles, L, DeMasi, R, Zeuzem, S

Get full text

Add-on Peginterferon Alfa-2a significantly reduces HBsAg levels in chronic hepatitis B, HBeAg-negative, genotype D patients fully suppressed on nucleot(s)ide analogues treatment: HERMES Study Interim Analysis by Lampertico, P, Brunetto, M.R, Craxì, A, Gaeta, G.B, Rizzetto, M, Palmieri, G, Colombo, M

Get full text

P.10.1 REACTIVATION OF HEPATITIS B VIRUS IN CANCER PATIENTS TREATED WITH CHEMOTHERAPY FOR SOLID TUMORS. IS THE PROPHYLAXIS REALLY REQUIRED? by Federico, A, Dallio, M, Brancaccio, G, Iodice, P, Fabozzi, A, Del Prete, S, Ciardiello, F, Gaeta, G.B, Loguercio, C

Get full text

Adherence to Guidelines in Field-Practice: Progetto Epatocarcinoma Campania by Di Costanzo, G.G, Guarino, M, De Stefano, G, Coppola, C, Tortora, R, Morisco, F, Angelo, S.M, Izzo, F, Nardone, G, Piai, G, Adinolfi, L.E, D’Adamo, G, Gaeta, G.B, Messina, V, Francica, G, De Girolamo, V, Coppola, N

Get full text

DAA-based regimens in HBsAg/anti-HCV positive patients: The need to control HBV replication to avoid HBV reactivation by Macera, M, Stanzione, M, Messina, V, D’Adamo, G, Sangiovanni, V, Fontanella, L, De Pascalis, S, Stornaiuolo, G, Piai, G, Gaeta, G.B, Gentile, I, Coppola, N

Get full text

Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study by Ippolito, A.M, Milella, M, Messina, V, Conti, F, Cozzolongo, R, Morisco, F, Brancaccio, G, Barone, M, Santantonio, T, Fasano, M, Masetti, C, Tundo, P, Smedile, A, Carretta, V, Gatti, P, Termite, A.P, Valvano, M.R, Bruno, G, Fabrizio, C, Andreone, P, Zappimbulso, M, Gaeta, G.B, Napoli, N, Fontanella, L, Lauletta, G, Cuccorese, G, Metrangolo, A, Francavilla, R, Ciracì, E, Rizzo, S, Andriulli, A

Get full text

Diagnostic and therapeutic approaches of mixed cryoglobulinemia in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort by Kondili, L.A, Monti, M, Gaeta, G.B, Rizzo, V, Borgia, G, Zappulo, E, Chemello, L, Cavalletto, L, Vinci, M, Palladini, S, Andreone, P, Margotti, M, Puoti, M, Danieli, E, Persico, M, Masarone, M, Madonia, S, Brunetto, M.R, Coco, B, Ieluzzi, D, Passigato, N, Rumi, M.G, Sciola, V, Massari, M, Corsini, R, Mazzella, G, Lazzarini, G, Taliani, G, Biliotti, E, Andreoni, M, Cerva, C, Alberti, A, Gonzo, M, Chessa, L, Pasetto, M.C, Federico, A, Dallio, M, Quaranta, M.G, Weimer, L.E, Vella, S, Zignego, A.L

Get full text

Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER) by Kondili, L.A, Di Leo, A, Iannone, A, Santantonio, T, Giammario, A, Raimondo, G, Filomia, R, Coppola, C, Amoruso, D, Blanc, P, Del Pin, B, Chemello, L, Cavalletto, L, Morisco, F, Donnarumma, L, Rumi, M.G, Gasbarrini, A, Siciliano, M, Massari, M, Corsini, R, Brunetto, M.R, Coco, B, Madonia, S, Zignego, A.L, Monti, M, Russo, F.P, Zanetto, A, Persico, M, Masarone, M, Villa, E, Bernabucci, V, Taliani, G, Biliotti, E, Chessa, L, Pasetto, M.C, Andreone, P, Margotti, M, Gaeta, G.B, Rizzo, V, Ieluzzi, D, Borgia, G, Zappulo, E, Calvaruso, V, Petta, S, Rolli, F.R, Falzano, L, Rosato, S, Ruggeri, M

Get full text

Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapies by Di Maio, V.C, Cento, V, Lenci, I, Aragri, M, Barbaliscia, S, Francioso, S, Paolucci, S, Melis, M, Verucchi, G, Coppola, N, Magni, C.F, Micheli, V, Pollicino, T, Ruggiero, T, Santopaolo, F, Landonio, S, Mancon, A, Starace, M, Bertoli, A, Antonucci, F.P, D’Ambrosio, C, Calvaruso, V, Morisco, F, Pasquazzi, C, Maida, I, Picciotto, A, Biagio, A.D, Bruzzone, B, Sticchi, L, Ghisetti, V, Cozzolongo, R, Romagnoli, D, Boccaccio, V, Grieco, A, Vecchiet, J, D’Ettorre, G, Merli, M, Gaeta, G.B, Ciancio, A, Marinaro, L, Andreone, P, Barbarini, G, Gulminetti, R, Palitti, V.P, Tarquini, P, Puoti, M, Sangiovanni, V, Stefano, G.D, Giorgini, A, Paoloni, M, Caporaso, N, Babudieri, S, Gubertini, G, Bruno, S, Andreoni, M, Pellicelli, A, Parruti, G, Raimondo, G, Baldanti, F, Craxì, A, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

Virological Failures to New Direct Acting Antivirals in a Real Life Setting May Require Unconventional Regimens for Re-Treatment by Di Maio, V.C, Cento, V, Di Paolo, D, Lenci, I, Aragri, M, Verucchi, G, Melis, M, Bertoli, A, Antonucci, F.P, Francioso, S, Pellicelli, A, Calvaruso, V, Pasquazzi, C, Romagnoli, D, Biolato, M, Vecchiet, J, Morisco, F, Merli, M, Gaeta, G.B, Brillanti, S, Donato, F, Puoti, M, Pisani, V, Paoloni, M, Babudieri, S, Craxì, A, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

HCV–Related Mixed Cryoglobulinemia: Data from Piter, a Nationwide Italian HCV Cohort Study by Kondili, L, Weimer, L.E, Mallano, A, Fucili, L, Massella, M, Vinci, M, Borgia, G, Brunetto, M, Surace, L, Gaeta, G.B, Chemello, L, Andreone, P, Raimondo, G, Filomia, R, Persico, M, Puoti, M, Rumi, M.G, Benedetti, A, Fargion, S, Ieluzzi, D, Nardone, G, Giuseppe, F, Ciancio, A, Taliani, G, Biliotti, E, Madonia, S, Stagno, B, Alberti, A, Massari, M, Rosina, F, Mazzella, G, Di Leo, A, Iannone, A, Ferrari, C, Orlandini, A, Monti, M, Santantonio, T.A, Chessa, L, Erne, E.M, Coppola, C, Andreoni, M, Baldelli, F, Mondelli, M, Blanc, P, Gasbarrini, A, Verucchi, G, Colombo, M, Borghi, M, Craxì, A, Petta, S, Villa, E, Patti, O, Russo, F.P, Strazzabosco, M, Vella, S, Zignego, A.L

Get full text

Gender Differences in HCV Chronic Liver Disease: A Real Life Evaluation in Piter (Piattaforma Italiana per Lo Studio Della Terapia Delle Epatiti Virali) Cohort Study by Kondili, L, Quaranta, M.G, Falzano, L, Di Gregorio, M, Brunetto, M, Zignego, A.L, Ciancio, A, Di Leo, A, Rendina, M, Raimondo, G, Ferrari, C, Craxì, A, Taliani, G, Borgia, G, Gentile, I, Santantonio, T.A, Giammario, A, Blanc, P, Gaeta, G.B, Gasbarrini, A, Siciliano, M, Chessa, L, Erne, E.M, Ieluzzi, D, Russo, F.P, Andreone, P, Vinci, M, Coppola, C, Chemello, L, Madonia, S, Verucchi, G, Persico, M, Zuin, M, Alberti, A, Puoti, M, Nardone, G, De Maria, V, Massari, M, Montalto, G, Foti, G, Rumi, M.G, Giacometti, A, Benedetti, A, D’Offizi, G, Strazzabosco, M, Fargion, S, Angarano, G, Federico, A, Caporaso, N, Mastroianni, C, Toniutto, P, Colombo, M, Lazzarin, A, Torti, C, Andreoni, M, Rosina, F, Viscoli, C, Vella, S, Villa, E

Get full text

O117 : Predictors of clinical response: Results from a large, randomized controlled study with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB) by Chan, H.L, Ahn, S.H, Chuang, W.L, Hui, A.J, Tabak, F, Mehta, R, Petersen, J, Lee, C.-M, Ma, X, Caruntu, F.A, Tak, W.Y, Elkhashab, M, Lin, L, Dinh, P, Martins, E.B, Charuworn, P, McHutchinson, J.G, Subramanian, G.M, Lim, S.G, Foster, G.R, Fung, S, Morano, L, Samuel, D, Agarwal, K, Idilman, R, Strasser, S, Buti, M, Gaeta, G.B, Papatheodoridis, G, Flisiak, R, Marcellin, P

Get full text